Today, I sold the shares of GERN-Geron Corp. I bought last year. They had the news I was looking for, and the monthly chart reached an area of prior resistance at 8 dollars. With any biotech stock, I always sell into volume spikes that are news driven. While this is great news, it’s still only a 1st phase trial with 8-10 people, which will be studied for a year.
If you’d caught the news early, GERN gave an excellent reward to risk entry on the first pullback of it’s 5-minute chart.
